HCAN:PA:PA-HSBC MSCI Canada UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 20.939

Change

-0.12 (-0.58)%

Market Cap

USD 0.03B

Volume

2.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

+0.37 (+0.83%)

USD 67.33B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+0.70 (+0.14%)

USD 11.54B
WRD:PA HSBC ETFs Public Limited Compa..

+0.09 (+0.26%)

USD 9.41B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+1.55 (+0.65%)

USD 7.83B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+0.85 (+0.19%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.06 (+0.11%)

USD 7.02B
WLD:PA Lyxor UCITS MSCI World D-EUR

+0.88 (+0.27%)

USD 6.60B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.04 (+0.24%)

USD 5.52B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+0.30 (+0.08%)

USD 4.87B
500U:PA Amundi Index Solutions - Amund..

+0.28 (+0.26%)

USD 4.29B

ETFs Containing HCAN:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.97% 39% F 58% F
Dividend Return N/A 41% F 90% A-
Total Return N/A 51% F 57% F
Trailing 12 Months  
Capital Gain 7.70% 41% F 61% D-
Dividend Return N/A 64% D 55% F
Total Return N/A 87% B+ 66% D+
Trailing 5 Years  
Capital Gain 33.90% 50% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 33.90% 47% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 8.72% 63% D 63% D
Dividend Return N/A 54% F 84% B
Total Return N/A 50% F 59% D-
Risk Return Profile  
Volatility (Standard Deviation) N/A 62% D 83% B
Risk Adjusted Return N/A 76% C+ 78% C+
Market Capitalization 0.03B 13% F 28% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.